11:00 - 11:10 am |
Introduction to CMHC Women's Health Summit |
11:10 - 11:55 am |
NEW! Cardio-oncology: Overview and the Intersection Between Breast Cancer and Cardiovascular Disease |
12:00 - 1:00 pm |
Repatha® (evolocumab): Putting it into Practice Sponsored by Amgen, Inc. |
1:10 - 1:15 pm |
Welcome Back to Women’s Health Summit |
1:15 - 1:45 pm |
Cardiometabolic Risk in PCOS and Implications for Management |
1:45 - 2:15 pm |
Impact of Pregnancy on CV Risk Factors and ASCVD Risk |
2:15 - 2:30 pm |
Nutrition Break |
2:30 - 3:00 pm |
Choosing Wisely: Contraception in Women with Cardiometabolic Risk |
3:00 - 3:30 pm |
Updates on the Role of Postmenopausal Hormone Replacement Therapy |
3:30 - 3:50 pm |
NEW! Women’s Health Summit Expert Panel Discussion and Q&A Chair: Pamela B. Morris, MD Panelists: Ana Barac, MD; Andrea Dunaif, MD; Nieca Goldberg, MD; Pam R. Taub, MD; JoAnn E. Manson, MD, DrPH, FAHA |
3:50 - 4:00 pm |
Conclusions to CMHC Women’s Health Summit |
4:00 - 4:15 pm |
Mini Break |
4:15 - 5:15 pm |
PME Light Bites Session (Non-CME) Gaining Access to PCSK9 Inhibitors: Dissemination of a Mobile App & More Sponsored by Amgen, Inc. and Sanofi Regeneron. |
5:30 - 6:30 pm |
PME Light Bites Session (Non-CME) Long-Term Results of Treatment Across a Broad Range of Patients With Type 2 Diabetes Sponsored by Janssen Pharmaceuticals, Inc. |
6:45 - 7:45 pm |
PME Dinner Symposium (Non-CME) The Role of VASCEPA® (icosapent ethyl): Topline Results from REDUCE-IT™ Sponsored by Amarin Pharma, Inc. |
Session I: Diabetes Management |
|
6:30 - 7:45 am |
NEW! CME Breakfast Symposium A The Role of CGM in Individualization of T2DM Management Chair: Anne L. Peters, MD Presenter: Irl B. Hirsch, MD Supported by educational grants from Dexcom, Inc. and Medtronic. |
6:30 - 7:45 am |
Non-Medical Switching, Barriers and Consequences Chair: Seth J. Baum, MD, FASPC Presenters: Kim Newlin, NP, CNS, FPCNA, FAHA; Michael Wong, JD Supported by educational grants from BMS Pfizer Alliance and Janssen Pharmaceuticals, Inc. |
7:55 - 8:00 am |
Opening Remarks |
8:00 - 9:30 am |
FDA Update and Late Breaking Clinical Trials Chair: Christie M. Ballantyne, MD Presenters: Robert H. Eckel, MD; Jay S. Skyler, MD; Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH |
9:30 - 10:15 am |
KEYNOTE New Dimensions in Insulin Action and Why They are Important to Know |
10:15 - 11:15 am |
Morning Break - Exhibit Hall |
10:20 - 11:15 am |
Small Group Workshops* Insulin Biosimilars Faculty: Anne L. Peters, MD |
11:15 am - 12:00 pm |
So Many Options - Dispelling the Confusion About Insulins This session is supported by an educational grant from Novo Nordisk. |
12:10 - 1:25 pm |
Management of T2DM Patients with Diabetic Kidney Disease: Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Disease Progression Chair: Matthew R. Weir, MD Presenters: Lance Sloan, MD; Robert D. Toto, MD Supported by educational grants from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC. and by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC |
12:10 - 1:25 pm |
Advances in HFpEF: Addressing Diagnostic and Treatment Challenges Chair: JoAnn Lindenfeld, MD Presenters: Keith C. Ferdinand, MD; Alanna A. Morris, MD Supported by an educational grant from Novartis Pharmaceuticals Corporation. |
1:35 - 2:20 pm |
Where Are We With Devices for Diabetes Management? |
2:20 - 3:20 pm |
Afternoon Break - Exhibit Hall |
3:20 - 3:50 pm |
How Many GLP-1 RAs Do We Need and Why? |
3:50 - 5:05 pm |
Multidisciplinary Case Consults in Diabetes Management Chair: Jay S. Skyler, MD Panelists: John B. Buse, MD; Robert H. Eckel, MD; Davida F. Kruger, MSN, APNBC, BCADM; Anne L. Peters, MD; Irl B. Hirsch, MD |
4:00 - 4:45 pm |
Small Group Workshops* Real-World Digital Health Implementations to Improve Blood Pressure Control Kate Kirley, MD, MS; Janet Williams, MA Hosted in Collaboration with the American Medical Association. |
5:10 - 6:10 pm |
Welcome Reception - Exhibit Hall |
6:15 - 7:30 pm |
NEW! CME Dinner Symposium Mastering the Prior Authorization Process to Meet Patient Needs Chair: Pamela B. Morris, MD Presenters: Christie M. Ballantyne, MD; Kim K. Birtcher, PharmD; Matthew Stryker, PharmD, BCACP, CLS Supported by an educational grant from Sanofi US and Regeneron Pharmaceuticals and in partnership with The Doctor-Patient Rights Project. |
Session II: Obesity and Lifestyle Management in Cardiovascular Disease |
|
6:30 - 7:45 am |
NEW! CME Breakfast Symposium A The ABC Access Program: Overcoming Barriers to Access of Newer Cardiovascular Agents for High-Risk and Minority Patients Chair: Keith C. Ferdinand, MD Presenters: Deirdre J. Mattina, MD; Catherine Davis Ahmed, MBA Supported by an educational funding donation provided by Amgen and in partnership with the Association of Black Cardiologists, Inc (ABC). |
6:30 - 7:45 am |
Cardiovascular Risk Reduction in T2DM: Applying the Trial Data to Clinical Practice Chair: Robert H. Eckel, MD Presenters: Harold E. Bays, MD; Deepak L. Bhatt, MD, MPH; Lawrence Blonde, MD Supported by educational grants from AstraZeneca and Novo Nordisk. |
7:55 - 8:00 am |
Opening Remarks |
8:00 - 8:45 am |
Interventional Cardiology Delivered With a Fork |
8:45 - 9:15 am |
Updates on Metabolic Surgery |
9:15 - 10:00 am |
Obesity and Environmental Influence: The Big Picture |
10:00 - 11:00 am |
Morning Break - Exhibit Hall |
10:05 - 10:50 am |
Small Group Workshops* Prevent Type 2 Diabetes with Digital Health: Effective and Realistic Solutions Kate Kirley, MD, MS; Janet Williams, MA Hosted in Collaboration with the American Medical Association. |
11:00 - 11:45 am |
Day to Day Management of Obesity in Clinical Practice |
11:45 - 11:50 am |
Closing Remarks |
12:00 - 1:15 pm |
Identifying, Diagnosing and Managing Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life Chair: Eldrin F. Lewis, MD, MPH Presenters: Akshay S. Desai, MD, MPH; Gurusher S. Panjrath, MD, FACC, FAHA Supported by an educational grant from American Regent. |
12:00 - 1:15 pm |
CME Lunch Symposium B Chair: Robert E. Ratner, MD Presenters: Robert H. Eckel, MD; Davida Kruger, MSN, APN-BC, BCADM; Deborah J. Wexler, MD Supported by an educational grant from Sanofi US. |
Session III: Dyslipidemia, Atherosclerosis, and Cardiovascular Disease Risk Reduction |
|
1:25 - 1:30 pm |
Opening Remarks |
1:30 - 2:20 pm |
Targeting Inflammation: Updates on Pathophysiology and Clinical Outcomes Peter Libby, MD; This session is supported by an educational grant from Novartis Pharmaceuticals Corporation. |
2:20 - 3:20 pm |
Afternoon Break - Exhibit Hall |
3:25 - 4:10 pm |
Small Group Workshops* Don't Hit the Snooze Button on Sleep: The Role of Sleep in Cardiometabolic Health Hosted in Collaboration with the American Academy of Sleep Medicine. |
3:20 - 4:10 pm |
How Aggressively Do We Lower LDL-C and For Which Patients? |
4:10 - 5:00 pm |
Risk Assessment for Global Cardiovascular Disease: Imaging and Biomarkers |
5:00 - 6:00 pm |
Multidisciplinary Case Consults in Lipid Disorders Chair: Christie M. Ballantyne, MD Panelists: Robert H. Eckel, MD; Pamela B. Morris, MD; Margo B. Minissian, PhD, ACNP; Pam R. Taub, MD; Vera A. Bittner, MD, MSPH This session is supported by educational grants from Amarin Pharma, Inc and Akcea Therapeutics. |
6:00 - 6:05 pm |
Closing Remarks |
6:05 - 7:05 pm |
Closing Reception - Exhibit Hall |
7:15 - 8:15 pm |
PME Dinner Symposium (Non-CME) Advancements in the Management of Patients with Type 2 Diabetes: Results from a Large Cardiovascular Outcomes TrialRonald D’Agostino, DO, FACC, FACP Sponsored by Novo Nordisk |
Session IV: Hypertension, Cardio-renal, and Heart Failure |
|
6:30 - 7:45 am |
NEW! CME Breakfast Symposium Chair: George L. Bakris, MD Presenter: Keith C. Ferdinand, MD Supported by an educational grant from Relypsa, Inc. |
7:55 - 8:00 am |
Opening Remarks |
8:00 - 9:00 am |
Overview of the New 2017 Hypertension Clinical Practice Guidelines |
9:00 - 9:30 am |
Comparing the Hypertension Guidelines - Where is the Equipoise? |
9:30 - 9:45 am |
Nutrition Break |
9:45 - 10:45 am |
Patient Cases: How would you change the management of hypertension based on the new guidelines? Aldo Peixoto, MD; Michael A. Weber, MD; Keith C. Ferdinand, MD |
10:45 - 11:15 am |
Prevention of Heart Failure: The Next Frontier |
11:15 - 11:25 am |
Mini Break |
11:25 - 11:55 am |
Integration of Biomarkers and Prediction of AKI and Cardio-renal Outcomes in Clinical Practice |
11:55 am - 12:25 pm |
AKI and Heart Failure: How to manage compared to general population? |
12:25 - 12:55 pm |
Advanced CKD and Benefits From CVOTs |
12:55 - 1:00 pm |
Closing Remarks |
11:00 - 11:10 am |
Introduction to CMHC Women's Health Summit |
11:10 - 11:55 am |
Cardio-oncology: Overview and the Intersection Between Breast Cancer and Cardiovascular Disease |
12:00 - 1:00 pm |
Repatha® (evolocumab): Putting it into Practice Sponsored by Amgen, Inc. |
1:10 - 1:15 pm |
Welcome Back to Women’s Health Summit |
1:15 - 1:45 pm |
Cardiometabolic Risk in PCOS and Implications for Management |
1:45 - 2:15 pm |
Impact of Pregnancy on CV Risk Factors and ASCVD Risk |
2:15 - 2:30 pm |
Nutrition Break |
2:30 - 3:00 pm |
Choosing Wisely: Contraception in Women with Cardiometabolic Risk |
3:00 - 3:30 pm |
Updates on the Role of Postmenopausal Hormone Replacement Therapy |
3:30 - 3:50 pm |
Women’s Health Summit Expert Panel Discussion and Q&A Chair: Pamela B. Morris, MD Panelists: Ana Barac, MD; Andrea Dunaif, MD; Nieca Goldberg, MD; Pam R. Taub, MD; JoAnn E. Manson, MD, DrPH, FAHA |
3:50 - 4:00 pm |
Conclusions to CMHC Women’s Health Summit |
4:00 - 4:15 pm |
Mini Break |
4:15 - 5:15 pm |
PME Light Bites Session (Non-CME) Gaining Access to PCSK9 Inhibitors: Dissemination of a Mobile App & More Sponsored by Amgen, Inc. and Sanofi Regeneron. |
5:30 - 6:30 pm |
PME Light Bites Session (Non-CME) Long-Term Results of Treatment Across a Broad Range of Patients With Type 2 Diabetes Sponsored by Janssen Pharmaceuticals, Inc. |
6:45 - 7:45 pm |
PME Dinner Symposium (Non-CME) The Role of VASCEPA® (icosapent ethyl): Topline Results from REDUCE-IT™ Sponsored by Amarin Pharma, Inc. |
3:50 - 5:05 pm |
Multidisciplinary Case Consults in Diabetes Management Chair: Jay S. Skyler, MD Panelists: John B. Buse, MD; Robert H. Eckel, MD; Davida F. Kruger, MSN, APNBC, BCADM; Anne L. Peters, MD; Irl B. Hirsch, MD |
5:00 - 6:00 pm |
Multidisciplinary Case Consults in Lipid Disorders Chair: Christie M. Ballantyne, MD Panelists: Robert H. Eckel, MD; Pamela B. Morris, MD; Margo B. Minissian, PhD, ACNP; Pam R. Taub, MD; Vera A. Bittner, MD, MSPH This session is supported by educational grants from Amarin Pharma, Inc and Akcea Therapeutics. |
6:30 - 7:45 am |
The Role of CGM in Individualization of T2DM Management Chair: Anne L. Peters, MD Presenter: Irl B. Hirsch, MD Supported by educational grants from Dexcom, Inc. and Medtronic. |
6:30 - 7:45 am |
Non-Medical Switching, Barriers and Consequences Chair: Seth J. Baum, MD, FASPC Presenters: Kim Newlin, NP, CNS, FPCNA, FAHA; Michael Wong, JD Supported by educational grants from BMS Pfizer Alliance and Janssen Pharmaceuticals, Inc. |
12:10 - 1:25 pm |
Management of T2DM Patients with Diabetic Kidney Disease: Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Disease Progression Chair: Matthew R. Weir, MD Presenters: Lance Sloan, MD; Robert D. Toto, MD Supported by educational grants from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC. and by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC |
12:10 - 1:25 pm |
Advances in HFpEF: Addressing Diagnostic and Treatment Challenges Chair: JoAnn Lindenfeld, MD Presenters: Keith C. Ferdinand, MD; Alanna A. Morris, MD Supported by an educational grant from Novartis Pharmaceuticals Corporation. |
6:15 - 7:30 pm |
Mastering the Prior Authorization Process to Meet Patient Needs Chair: Pamela B. Morris, MD Presenters: Christie M. Ballantyne, MD; Kim K. Birtcher, PharmD; Matthew Stryker, PharmD, BCACP, CLS Supported by an educational grant from Sanofi US and Regeneron Pharmaceuticals and in partnership with The Doctor-Patient Rights Project. |
6:30 - 7:45 am |
The ABC Access Program: Overcoming Barriers to Access of Newer Cardiovascular Agents for High-Risk and Minority Patients Chair: Keith C. Ferdinand, MD Presenters: Deirdre J. Mattina, MD; Catherine Davis Ahmed, MBA Supported by an educational funding donation provided by Amgen and in partnership with the Association of Black Cardiologists, Inc (ABC). |
6:30 - 7:45 am |
Cardiovascular Risk Reduction in T2DM: Applying the Trial Data to Clinical Practice Chair: Robert H. Eckel, MD Presenters: Harold E. Bays, MD; Deepak L. Bhatt, MD, MPH; Lawrence Blonde, MD Supported by educational grants from AstraZeneca and Novo Nordisk. |
12:00 - 1:15 pm |
Identifying, Diagnosing and Managing Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life Chair: Eldrin F. Lewis, MD, MPH Presenters: Akshay S. Desai, MD, MPH; Gurusher S. Panjrath, MD, FACC, FAHA Supported by an educational grant from American Regent. |
12:00 - 1:15 pm |
CME Lunch Symposium B Chair: Robert E. Ratner, MD Presenters: Robert H. Eckel, MD; Davida Kruger, MSN, APN-BC, BCADM; Deborah J. Wexler, MD Supported by an educational grant from Sanofi US. |
6:30 - 7:45 am |
CME Breakfast Symposium Chair: George L. Bakris, MD Presenter: Keith C. Ferdinand, MD Supported by an educational grant from Relypsa, Inc. |
10:15 - 11:15 am |
Morning Break - Exhibit Hall |
2:20 - 3:20 pm |
Afternoon Break - Exhibit Hall |
10:00 - 11:00 am |
Morning Break - Exhibit Hall |
2:20 - 3:20 pm |
Afternoon Break - Exhibit Hall |
7:55 - 8:00 am |
Opening Remarks |
8:00 - 9:30 am |
FDA Update and Late Breaking Clinical Trials Chair: Christie M. Ballantyne, MD Presenters: Robert H. Eckel, MD; Jay S. Skyler, MD; Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH |
9:30 - 10:15 am |
KEYNOTE New Dimensions in Insulin Action and Why They are Important to Know |
11:15 am - 12:00 pm |
So Many Options - Dispelling the Confusion About Insulins This session is supported by an educational grant from Novo Nordisk. |
1:35 - 2:20 pm |
Where Are We With Devices for Diabetes Management? |
3:20 - 3:50 pm |
How Many GLP-1 RAs Do We Need and Why? |
3:50 - 5:05 pm |
Multidisciplinary Case Consults in Diabetes Management Chair: Jay S. Skyler, MD Panelists: John B. Buse, MD; Robert H. Eckel, MD; Davida F. Kruger, MSN, APNBC, BCADM; Anne L. Peters, MD; Irl B. Hirsch, MD |
7:55 - 8:00 am |
Opening Remarks |
8:45 - 9:15 am |
Updates on Metabolic Surgery |
9:15 - 10:00 am |
Obesity and Environmental Influence: The Big Picture |
11:00 - 11:45 am |
Day to Day Management of Obesity in Clinical Practice |
11:45 - 11:50 am |
Closing Remarks |
3:20 - 4:10 pm |
How Aggressively Do We Lower LDL-C and For Which Patients? |
4:10 - 5:00 pm |
Risk Assessment for Global Cardiovascular Disease: Imaging and Biomarkers |
5:00 - 6:00 pm |
Multidisciplinary Case Consults in Lipid Disorders Chair: Christie M. Ballantyne, MD Panelists: Robert H. Eckel, MD; Pamela B. Morris, MD; Margo B. Minissian, PhD, ACNP; Pam R. Taub, MD; Vera A. Bittner, MD, MSPH This session is supported by educational grants from Amarin Pharma, Inc and Akcea Therapeutics. |
6:00 - 6:05 pm |
Closing Remarks |
7:55 - 8:00 am |
Opening Remarks |
8:00 - 9:00 am |
Overview of the New 2017 Hypertension Clinical Practice Guidelines |
9:00 - 9:30 am |
Comparing the Hypertension Guidelines - Where is the Equipoise? |
9:45 - 10:45 am |
Patient Cases: How would you change the management of hypertension based on the new guidelines? Aldo Peixoto, MD; Michael A. Weber, MD; Keith C. Ferdinand, MD |
10:45 - 11:15 am |
Prevention of Heart Failure: The Next Frontier |
11:25 - 11:55 am |
Integration of Biomarkers and Prediction of AKI and Cardio-renal Outcomes in Clinical Practice |
11:55 am - 12:25 pm |
AKI and Heart Failure: How to manage compared to general population? |
12:25 - 12:55 pm |
Advanced CKD and Benefits From CVOTs |
12:55 - 1:00 pm |
Closing Remarks |
9:30 - 10:15 am |
KEYNOTE New Dimensions in Insulin Action and Why They are Important to Know |
8:00 - 9:30 am |
FDA Update and Late Breaking Clinical Trials Chair: Christie M. Ballantyne, MD Presenters: Robert H. Eckel, MD; Jay S. Skyler, MD; Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH |
12:00 - 1:00 pm |
Repatha® (evolocumab): Putting it into Practice Sponsored by Amgen, Inc. |
4:15 - 5:15 pm |
PME Light Bites Session (Non-CME) Gaining Access to PCSK9 Inhibitors: Dissemination of a Mobile App & More Sponsored by Amgen, Inc. and Sanofi Regeneron. |
5:30 - 6:30 pm |
PME Light Bites Session (Non-CME) Long-Term Results of Treatment Across a Broad Range of Patients With Type 2 Diabetes Sponsored by Janssen Pharmaceuticals, Inc. |
6:45 - 7:45 pm |
PME Dinner Symposium (Non-CME) The Role of VASCEPA® (icosapent ethyl): Topline Results from REDUCE-IT™ Sponsored by Amarin Pharma, Inc. |
7:15 - 8:15 pm |
PME Dinner Symposium (Non-CME) Advancements in the Management of Patients with Type 2 Diabetes: Results from a Large Cardiovascular Outcomes TrialRonald D’Agostino, DO, FACC, FACP Sponsored by Novo Nordisk |
5:10 - 6:10 pm |
Welcome Reception - Exhibit Hall |
6:05 - 7:05 pm |
Closing Reception - Exhibit Hall |
10:20 - 11:15 am |
Small Group Workshops* Insulin Biosimilars Faculty: Anne L. Peters, MD |
4:00 - 4:45 pm |
Small Group Workshops* Real-World Digital Health Implementations to Improve Blood Pressure Control Kate Kirley, MD, MS; Janet Williams, MA Hosted in Collaboration with the American Medical Association. |
10:05 - 10:50 am |
Small Group Workshops* Prevent Type 2 Diabetes with Digital Health: Effective and Realistic Solutions Kate Kirley, MD, MS; Janet Williams, MA Hosted in Collaboration with the American Medical Association. |
3:25 - 4:10 pm |
Small Group Workshops* Don't Hit the Snooze Button on Sleep: The Role of Sleep in Cardiometabolic Health Hosted in Collaboration with the American Academy of Sleep Medicine. |
6:30 - 7:45 am |
Non-Medical Switching, Barriers and Consequences Chair: Seth J. Baum, MD, FASPC Presenters: Kim Newlin, NP, CNS, FPCNA, FAHA; Michael Wong, JD Supported by educational grants from BMS Pfizer Alliance and Janssen Pharmaceuticals, Inc. |
6:15 - 7:30 pm |
Mastering the Prior Authorization Process to Meet Patient Needs Chair: Pamela B. Morris, MD Presenters: Christie M. Ballantyne, MD; Kim K. Birtcher, PharmD; Matthew Stryker, PharmD, BCACP, CLS Supported by an educational grant from Sanofi US and Regeneron Pharmaceuticals and in partnership with The Doctor-Patient Rights Project. |
6:30 - 7:45 am |
The ABC Access Program: Overcoming Barriers to Access of Newer Cardiovascular Agents for High-Risk and Minority Patients Chair: Keith C. Ferdinand, MD Presenters: Deirdre J. Mattina, MD; Catherine Davis Ahmed, MBA Supported by an educational funding donation provided by Amgen and in partnership with the Association of Black Cardiologists, Inc (ABC). |
11:10 - 11:55 am |
Cardio-oncology: Overview and the Intersection Between Breast Cancer and Cardiovascular Disease |
1:45 - 2:15 pm |
Impact of Pregnancy on CV Risk Factors and ASCVD Risk |
8:00 - 9:30 am |
FDA Update and Late Breaking Clinical Trials Chair: Christie M. Ballantyne, MD Presenters: Robert H. Eckel, MD; Jay S. Skyler, MD; Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH |
6:30 - 7:45 am |
Cardiovascular Risk Reduction in T2DM: Applying the Trial Data to Clinical Practice Chair: Robert H. Eckel, MD Presenters: Harold E. Bays, MD; Deepak L. Bhatt, MD, MPH; Lawrence Blonde, MD Supported by educational grants from AstraZeneca and Novo Nordisk. |
1:30 - 2:20 pm |
Targeting Inflammation: Updates on Pathophysiology and Clinical Outcomes Peter Libby, MD; This session is supported by an educational grant from Novartis Pharmaceuticals Corporation. |
4:10 - 5:00 pm |
Risk Assessment for Global Cardiovascular Disease: Imaging and Biomarkers |
6:30 - 7:45 am |
The Role of CGM in Individualization of T2DM Management Chair: Anne L. Peters, MD Presenter: Irl B. Hirsch, MD Supported by educational grants from Dexcom, Inc. and Medtronic. |
7:55 - 8:00 am |
Opening Remarks |
8:00 - 9:30 am |
FDA Update and Late Breaking Clinical Trials Chair: Christie M. Ballantyne, MD Presenters: Robert H. Eckel, MD; Jay S. Skyler, MD; Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH |
9:30 - 10:15 am |
KEYNOTE New Dimensions in Insulin Action and Why They are Important to Know |
11:15 am - 12:00 pm |
So Many Options - Dispelling the Confusion About Insulins This session is supported by an educational grant from Novo Nordisk. |
12:10 - 1:25 pm |
CME Lunch Symposium A Chair: Matthew R. Weir, MD Presenters: Lance Sloan, MD; Robert D. Toto, MD Supported by educational grants from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC. and by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC |
1:35 - 2:20 pm |
Where Are We With Devices for Diabetes Management? |
3:20 - 3:50 pm |
How Many GLP-1 RAs Do We Need and Why? |
3:50 - 5:05 pm |
Multidisciplinary Case Consults in Diabetes Management Chair: Jay S. Skyler, MD Panelists: John B. Buse, MD; Robert H. Eckel, MD; Davida F. Kruger, MSN, APNBC, BCADM; Anne L. Peters, MD; Irl B. Hirsch, MD |
6:30 - 7:45 am |
Cardiovascular Risk Reduction in T2DM: Applying the Trial Data to Clinical Practice Chair: Robert H. Eckel, MD Presenters: Harold E. Bays, MD; Deepak L. Bhatt, MD, MPH; Lawrence Blonde, MD Supported by educational grants from AstraZeneca and Novo Nordisk. |
12:00 - 1:15 pm |
CME Lunch Symposium B Chair: Robert E. Ratner, MD Presenters: Robert H. Eckel, MD; Davida Kruger, MSN, APN-BC, BCADM; Deborah J. Wexler, MD Supported by an educational grant from Sanofi US. |
12:10 - 1:25 pm |
Advances in HFpEF: Addressing Diagnostic and Treatment Challenges Chair: JoAnn Lindenfeld, MD Presenters: Keith C. Ferdinand, MD; Alanna A. Morris, MD Supported by an educational grant from Novartis Pharmaceuticals Corporation. |
12:00 - 1:15 pm |
Identifying, Diagnosing and Managing Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life Chair: Eldrin F. Lewis, MD, MPH Presenters: Akshay S. Desai, MD, MPH; Gurusher S. Panjrath, MD, FACC, FAHA Supported by an educational grant from American Regent. |
7:55 - 8:00 am |
Opening Remarks |
10:45 - 11:15 am |
Prevention of Heart Failure: The Next Frontier |
11:55 am - 12:25 pm |
AKI and Heart Failure: How to manage compared to general population? |
12:55 - 1:00 pm |
Closing Remarks |
8:00 - 9:30 am |
FDA Update and Late Breaking Clinical Trials Chair: Christie M. Ballantyne, MD Presenters: Robert H. Eckel, MD; Jay S. Skyler, MD; Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH |
7:55 - 8:00 am |
Opening Remarks |
8:00 - 9:00 am |
Overview of the New 2017 Hypertension Clinical Practice Guidelines |
9:00 - 9:30 am |
Comparing the Hypertension Guidelines - Where is the Equipoise? |
9:45 - 10:45 am |
Patient Cases: How would you change the management of hypertension based on the new guidelines? Aldo Peixoto, MD; Michael A. Weber, MD; Keith C. Ferdinand, MD |
12:55 - 1:00 pm |
Closing Remarks |
8:00 - 9:30 am |
FDA Update and Late Breaking Clinical Trials Chair: Christie M. Ballantyne, MD Presenters: Robert H. Eckel, MD; Jay S. Skyler, MD; Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH |
1:25 - 1:30 pm |
Opening Remarks |
1:30 - 2:20 pm |
Targeting Inflammation: Updates on Pathophysiology and Clinical Outcomes Peter Libby, MD; This session is supported by an educational grant from Novartis Pharmaceuticals Corporation. |
3:20 - 4:10 pm |
How Aggressively Do We Lower LDL-C and For Which Patients? |
4:10 - 5:00 pm |
Risk Assessment for Global Cardiovascular Disease: Imaging and Biomarkers |
5:00 - 6:00 pm |
Multidisciplinary Case Consults in Lipid Disorders Chair: Christie M. Ballantyne, MD Panelists: Robert H. Eckel, MD; Pamela B. Morris, MD; Margo B. Minissian, PhD, ACNP; Pam R. Taub, MD; Vera A. Bittner, MD, MSPH This session is supported by educational grants from Amarin Pharma, Inc and Akcea Therapeutics. |
6:00 - 6:05 pm |
Closing Remarks |
8:00 - 8:45 am |
Interventional Cardiology Delivered With a Fork |
8:00 - 9:30 am |
FDA Update and Late Breaking Clinical Trials Chair: Christie M. Ballantyne, MD Presenters: Robert H. Eckel, MD; Jay S. Skyler, MD; Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH |
7:55 - 8:00 am |
Opening Remarks |
8:45 - 9:15 am |
Updates on Metabolic Surgery |
9:15 - 10:00 am |
Obesity and Environmental Influence: The Big Picture |
11:00 - 11:45 am |
Day to Day Management of Obesity in Clinical Practice |
11:45 - 11:50 am |
Closing Remarks |
12:10 - 1:25 pm |
CME Lunch Symposium A Chair: Matthew R. Weir, MD Presenters: Lance Sloan, MD; Robert D. Toto, MD Supported by educational grants from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC. and by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC |
7:55 - 8:00 am |
Opening Remarks |
11:25 - 11:55 am |
Integration of Biomarkers and Prediction of AKI and Cardio-renal Outcomes in Clinical Practice |
11:55 am - 12:25 pm |
AKI and Heart Failure: How to manage compared to general population? |
12:25 - 12:55 pm |
Advanced CKD and Benefits From CVOTs |
12:55 - 1:00 pm |
Closing Remarks |
11:00 - 11:10 am |
Introduction to CMHC Women's Health Summit |
11:10 - 11:55 am |
Cardio-oncology: Overview and the Intersection Between Breast Cancer and Cardiovascular Disease |
1:10 - 1:15 pm |
Welcome Back to Women’s Health Summit |
1:15 - 1:45 pm |
Cardiometabolic Risk in PCOS and Implications for Management |
1:45 - 2:15 pm |
Impact of Pregnancy on CV Risk Factors and ASCVD Risk |
2:30 - 3:00 pm |
Choosing Wisely: Contraception in Women with Cardiometabolic Risk |
3:00 - 3:30 pm |
Updates on the Role of Postmenopausal Hormone Replacement Therapy |
3:30 - 3:50 pm |
Women’s Health Summit Expert Panel Discussion and Q&A Chair: Pamela B. Morris, MD Panelists: Ana Barac, MD; Andrea Dunaif, MD; Nieca Goldberg, MD; Pam R. Taub, MD; JoAnn E. Manson, MD, DrPH, FAHA |
3:50 - 4:00 pm |
Conclusions to CMHC Women’s Health Summit |